Lymphoid_JJ
cell_NN
resistance_NN
to_TO
glucocorticoids_NNS
in_IN
HIV_NN
infection_NN
._.

In_IN
humans_NNS
infected_VBN
with_IN
the_DT
HIV-1_NN
virus_NN
there_EX
may_MD
be_VB
a_DT
disproportionate_JJ
severity_NN
of_IN
signs_NNS
and_CC
symptoms_NNS
of_IN
illness_NN
compared_VBN
to_TO
the_DT
fraction_NN
of_IN
CD4_NN
+_CC
infected_JJ
T-lymphoid_NN
cells_NNS
._.

In_IN
part_NN
,_,
this_DT
may_MD
be_VB
due_JJ
to_TO
altered_JJ
intercellular_JJ
signalling_NN
systems_NNS
and_CC
intracellular_JJ
signal_NN
transduction_NN
._.

Glucocorticoids_NNS
are_VBP
well_RB
known_VBN
for_IN
their_PRP$
effects_NNS
on_IN
the_DT
vitality_NN
and_CC
function_NN
of_IN
lymphoid_JJ
cells_NNS
._.

Patients_NNS
with_IN
HIV_NN
infections_NNS
often_RB
show_VBP
elevated_JJ
circulating_VBG
levels_NNS
of_IN
cortisol_NN
,_,
suggesting_VBG
some_DT
misfunction_NN
in_IN
the_DT
regulatory_JJ
systems_NNS
that_WDT
maintain_VBP
the_DT
levels_NNS
of_IN
this_DT
critical_JJ
hormone_NN
._.

At_IN
the_DT
cellular_JJ
level_NN
,_,
it_PRP
is_VBZ
known_VBN
that_IN
both_CC
acute_JJ
HIV_NN
infection_NN
and_CC
glucocorticoids_NNS
can_MD
cause_VB
apoptotic_JJ
cell_NN
death_NN
in_IN
thymic_JJ
lymphocytes_NNS
._.

However_RB
,_,
chronically_RB
HIV-infected_JJ
cells_NNS
appear_VBP
to_TO
be_VB
resistant_JJ
to_TO
glucocorticoid-evoked_JJ
cell_NN
death_NN
._.

Glucocorticoid_NN
receptor-ligand_JJ
binding_NN
studies_NNS
on_IN
patients_NNS
'_POS
cells_NNS
have_VBP
shown_VBN
reduced_VBN
affinity_NN
between_IN
the_DT
receptor_NN
binding_NN
sites_NNS
and_CC
test_NN
steroids_NNS
._.

In_FW
vitro_FW
,_,
chronically_RB
HIV-infected_JJ
cells_NNS
of_IN
the_DT
lymphoid_JJ
CEM_NN
line_NN
displayed_VBD
resistance_NN
to_TO
glucocorticoid-induced_JJ
apoptosis_NN
._.

These_DT
cells_NNS
showed_VBD
reduced_VBN
numbers_NNS
of_IN
binding_VBG
sites_NNS
with_IN
little_JJ
alteration_NN
in_IN
apparent_JJ
affinity_NN
between_IN
ligand_NN
and_CC
receptor_NN
._.

Thus_RB
it_PRP
appears_VBZ
that_IN
there_EX
may_MD
often_RB
be_VB
malfunction_NN
of_IN
the_DT
normal_JJ
glucocorticoid_NN
response_NN
in_IN
HIV-infected_JJ
cells_NNS
probably_RB
due_JJ
to_TO
altered_JJ
interactions_NNS
between_IN
the_DT
glucocorticoid_NN
receptor_NN
and_CC
its_PRP$
hormone_NN
._.

Such_JJ
alterations_NNS
may_MD
have_VB
clinical_JJ
consequences_NNS
,_,
including_VBG
the_DT
possibility_NN
of_IN
a_DT
relatively_RB
longer_JJR
life_NN
span_NN
of_IN
infected_JJ
CD4_NN
+_CC
T-lymphocytes_NNS
,_,
as_RB
well_RB
as_IN
systemic_JJ
effects_NNS
of_IN
chronically_RB
elevated_JJ
cortisol_NN
level_NN
._.

